Shanghai Fosun Pharma (Group) Co., Ltd. (“Fosun Pharma”, stock code: 600196.SH, 02196.HK) was founded in 1994. It is a global pharmaceutical and health industry group rooted in China and driven by innovation. The business operations include pharmaceuticals, medical devices and medical diagnosis, and medical and health services, and it covers the pharmaceutical business field through its participation in Sinopharm Holdings.

Fosun Pharma is patient-centered and clinical demand-oriented. Through independent research and development, cooperative development, licensing introduction, and in-depth incubation, Fosun Pharma continues to enrich its innovative product pipeline and improve FIC (First-in-class) and BIC (First-in-class) Best-in-class (best-in-class) new drug research and clinical development capabilities, accelerating the development and transformation of innovative technologies and products.